News Conference News ACC 2020 Low Mortality Rates Seen With Andexanet Alfa for Factor Xa-Related Bleeds Todd Neale March 25, 2020
News Daily News More Support for DOAC-Based Double Therapy After PCI for A-fib Patients Todd Neale March 16, 2020
News Daily News Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban Todd Neale March 09, 2020
News Daily News Antiplatelets Add Risk in Newly Diagnosed A-fib Patients: GARFIELD-AF Caitlin E. Cox March 02, 2020
News Daily News New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib Shelley Wood February 28, 2020
News Conference News ISC 2020 Optimal Time to Start Anticoagulation After Stroke Remains Unclear Todd Neale February 27, 2020
News Daily News No Stroke Reduction but Increased Bleeding With OAC in Dialysis Patients Todd Neale January 21, 2020
News Daily News Year in Review: Digital Health and A-fib Ablation Top 2019 Heart Rhythm News Todd Neale December 19, 2019
News Daily News Anticoagulation Prescription in the ED May Boost Later Use Todd Neale December 11, 2019
News Daily News Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights Shelley Wood December 02, 2019
News Conference News AHA 2019 Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS Todd Neale November 20, 2019
News Daily News Dabigatran Discontinuation Rate Highest Early After Treatment Begins Todd Neale November 12, 2019
News Daily News Anticoagulant Type May Influence Fracture Risk in A-fib Patients Todd Neale October 21, 2019
News Daily News New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR Todd Neale October 18, 2019
News Daily News Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit Shelley Wood October 14, 2019
News Conference News TCT 2019 AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups Todd Neale September 26, 2019
News Conference News ESC 2019 GARFIELD-AF Analysis Digs Into Impact of Bleeding in Newly Diagnosed A-fib Todd Neale September 12, 2019
News Conference News ESC 2019 Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints Todd Neale September 11, 2019